Cited by 75Mobile Health and mHealth ApplicationsDigital Mental Health InterventionsStatistical Methods in Clinical Trials

Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology

Open access
Goldberg, Simon B., Sun, Shufang, Carlbring, Per, Torous, John·2023·npj Digital Medicine

Abstract

Hundreds of randomized controlled trials (RCTs) have tested the efficacy of mobile health (mHealth) tools for a wide range of mental and behavioral health outcomes. These RCTs have used a variety of control condition types which dramatically influence the scientific inferences that can be drawn from a given study. Unfortunately, nomenclature across mHealth RCTs is inconsistent and meta-analyses commonly combine control conditions that differ in potentially important ways. We propose a typology of control condition types in mHealth RCTs. We define 11 control condition types, discuss key dimensions on which they differ, provide a decision tree for selecting and identifying types, and describe the scientific inferences each comparison allows. We propose a five-tier comparison strength gradation along with four simplified categorization schemes. Lastly, we discuss unresolved definitional, ethical, and meta-analytic issues related to the categorization of control conditions in mHealth RCTs.

AI snapshot

Written from the paper’s full text.

TL;DR

This paper proposes a typology for selecting and describing control conditions in mobile health randomized controlled trials, defining 11 control condition types and a five-tier comparison-strength scheme. It also offers a decision tree and four simplified coding schemes for trialists and meta-analysts.

Key findings

  • Defines 11 control condition types: No Treatment, Placebo-Minimal, Placebo-Active, TAU-Minimal, TAU-Active, mHealth Minimal Active, Dismantling Design, Additive Design, mHealth Comparative Efficacy, non-mHealth Other Active, and non-mHealth EBT.
  • Proposes a five-tier comparison strength gradation from Class V (No Treatment) to Class I (e.g., mHealth Comparative Efficacy, non-mHealth EBT, and Dismantling/Additive designs for components).
  • Offers four simplified categorization schemes: five-category, four-category, two-category passive vs. active, and two-category therapeutic vs. non-therapeutic.
  • Argues that meta-analyses commonly combine control conditions that differ in important ways, and that control condition type influences the scientific inferences and effect sizes that can be drawn from mHealth RCTs.

Methods

  • Conceptual/framework paper; no empirical sample or primary data analysis is reported.
  • Builds on prior guidelines for behavioral intervention control conditions and defines five dimensions of differentiation: intended to be therapeutic, intensity, intensity match, masking/expectancy match, and received by both groups.
  • Provides a decision tree, tables of examples, scientific inferences, comparison strength, and alternative coding schemes; the main analysis is narrative synthesis and framework development.

Limitations

  • Paper-stated: the framework may help guide control-group selection but cannot definitively identify the ideal control for any particular study; its value must be proven in utility, and boundaries between categories are fuzzy (e.g., intensity/expectancy match, TAU-Minimal vs. TAU-Active).
  • Paper-stated: unresolved definitional, ethical, and meta-analytic issues remain; future work should include a Delphi panel, measures to delineate similar control conditions, and coding of the existing mHealth RCT literature.
  • Evident from the text: the typology is not empirically validated or tested for reliability, and no data are presented showing that the proposed categories predict between-group effect sizes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-023-00923-7

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 47 cited sources checked · 0 supported · 0 flagged

  • Interpretationreasoning

    Ambiguity defining and categorizing control conditions impacts attempts to synthesize trends across mHealth RCTs.

    “Ambiguity defining and categorizing control conditions impacts attempts to synthesize trends across mHealth RCTs.”
    Quote in the paperSubstantial claim
  • Interpretationreasoning

    Control conditions that are not intended to be therapeutic have an upper bound on the comparison strength they provide.

    “Control conditions that are not intended to be therapeutic have an upper bound on the comparison strength they provide.”
    Quote in the paperNot a substantial claim
  • Premisecitation

    There are no established guidelines for designing and categorizing control conditions for mHealth RCTs.

    “However, there are no established guidelines for designing and categorizing control conditions for mHealth RCTs15,16”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [15] Lutz, J., Offidani, E., Taraboanta, L., Lakhan, S. E. & Campellone, T. R. Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Front. Digit. Health 4, 823977 (2022). source

      Not checked in the free run.

    • cites [16] Blease, C. Out of control: how to design digital placebos. Curr. Treat. Options Psychiatry 1–10 https://doi.org/10.1007/S40501-023-00290-W (2023). source

      Not checked in the free run.

  • Interpretationcitation

    Non-mHealth EBT Active provides the highest comparison strength.

    “We define a two-level distinction based on whether the non-mHealth control is a frontline evidence-based treatment (non-mHealth EBT Active), providing the highest comparison strength38, or another active control (non-mHealth Other Active) that is intended to be therapeutic but is not a frontline EBT.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [38] Goodheart, C. D. et al. Evidence-based practice in psychology. Am. Psychol. 61, 271–285 (2006). source

      Not checked in the free run.

  • Interpretationnone given

    mHealth RCTs have used a variety of control condition types that dramatically influence the scientific inferences that can be drawn from a given study.

    “These RCTs have used a variety of control condition types which dramatically influence the scientific inferences that can be drawn from a given study.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 46
  • May combine two claims. 15
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    Nomenclature across mHealth RCTs is inconsistent.

    “Unfortunately, nomenclature across mHealth RCTs is inconsistent”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    Meta-analyses commonly combine control conditions that differ in potentially important ways.

    “meta-analyses commonly combine control conditions that differ in potentially important ways.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given

    The proposed typology considers five dimensions: intended to be therapeutic, intensity, intensity match, masking/expectancy match, and received by both groups.

    “Our proposed typology considers five dimensions (Table 1): intended to be therapeutic, intensity, intensity match, masking/expectancy match, and received by both groups.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    The comparison strength increases as intensity increases among non-therapeutic controls.

    “The comparison strength increases as intensity increases.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Control condition intensity is an important consideration, particularly in mHealth context where many focal interventions are self-guided and of potentially modest intensity.

    “Control condition intensity is an important second consideration, particularly in the mHealth context where many focal interventions are self-guided and of potentially modest intensity.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    Non-therapeutic control conditions are further defined based on intensity: none (No Treatment), low (Placebo-Minimal), and high (Placebo-Active).

    “Non-therapeutic control conditions are further defined based on intensity: none (No Treatment), low (Placebo-Minimal), and high (Placebo-Active).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning

    Whether the treatment condition is masked and expectancy is likely matched between focal and control conditions is a consideration.

    “A fourth consideration is whether the treatment condition is masked and in such a way that expectancy is likely to be matched between focal and control conditions.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisereasoning

    Whether intensity is matched between focal intervention and control condition is a consideration.

    “A third consideration is whether the intensity is matched between the focal intervention and the control condition.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    Dismantling Design and Additive Design provide a strong comparison for the specific ingredients being tested, although alone they cannot be used to evaluate the effects of an intervention as a whole.

    “These designs provide a strong comparison for the specific ingredients being tested, although alone they cannot be used to evaluate the effects of an intervention as a whole.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [34] Bell, E. C., Marcus, D. K. & Goodlad, J. K. Are the parts as good as the whole? A meta-analysis of component treatment studies. J. Consult. Clin. Psychol. 81, 722–736 (2013). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisenone given

    Whether the control condition is received by both focal intervention and control groups is a consideration.

    “A fifth consideration is whether the control condition is received by both focal intervention and control groups.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    Meta-analyses commonly combine substantially different control conditions, which complicates interpretation of results.

    “Meta-analyses commonly combine substantially different control conditions, which complicates interpretation of results24.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [24] Bendtsen, M., McCambridge, J., Åsberg, K. & Bendtsen, P. Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta-analysis. Addiction 116, 1021–1033 (2021). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisereasoning

    TAU can vary in intensity, so this category is further graded into TAU-Minimal and TAU-Active.

    “However, TAU can vary in intensity, so this category is further graded into TAU-Minimal and TAU-Active.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Development of psychotherapy placebos remains challenging.

    “the development of psychotherapy placebos remains a challenging (and some might say impossible)9,33 task.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [9] Wampold, B. E. & Imel, Z. E. The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work 2nd edn (Routledge, 2015). source

      Not checked in the free run.

    • cites [33] Wampold, B. E., Frost, N. D. & Yulish, N. E. Placebo effects in psychotherapy: a flawed concept and a contorted history. Psychol. Conscious. Theory Res. Pract. 3, 108–120 (2016).

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationcitation

    There is a need for a consistently applied typology of control conditions as mHealth moves toward wider adoption within health systems.

    “As mHealth moves toward wider adoption within health systems3, there is a need for a consistently applied typology of control conditions.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3] FDA. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs. https://www.fda.gov/news-events/press-announcements/fda-clears-mobile-medical-app-help-those-opioid-use-disorder-stay-recovery-programs (2022).

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Studies with non-therapeutic control conditions can establish the impact of non-specific factors but cannot provide the highest comparison strength.

    “Studies with non-therapeutic control conditions are still scientifically valuable as they can establish the impact of non-specific factors12, but they cannot provide the highest comparison strength.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [12] Freedland, K. E. et al. The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel. J. Clin. Epidemiol. 110, 74–81 (2019). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationcitation

    Clarifying the universe of mHealth control condition types can help highlight the scientific questions each type can reasonably address and comparison strength each type provides.

    “Clarifying the universe of mHealth control condition types can help highlight the scientific questions each type can reasonably address and comparison strength each type provides12.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12] Freedland, K. E. et al. The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel. J. Clin. Epidemiol. 110, 74–81 (2019). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Several other aspects of modern mHealth RCTs do not fit neatly into the 11-category scheme.

    “Several other aspects of modern mHealth RCTs do not fit neatly into the 11-category scheme.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The ethical use of digital health tools remains an active area of investigation, with frameworks emerging but none yet consistently adopted.

    “The ethical use of digital health tools remains an active area of investigation, with frameworks emerging but none yet consistently adopted55,56.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [55] Nebeker, C., Bartlett Ellis, R. J. & Torous, J. Development of a decision-making checklist tool to support technology selection in digital health research. Transl. Behav. Med. 10, 1004–1015 (2020). source

      Not checked in the free run.

    • cites [56] Shen, F. X. et al. An ethics checklist for digital health research in psychiatry: viewpoint. J. Med. Internet Res. 24, e31146 (2022). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    Expectancy may or may not actually be matched across conditions in mHealth RCTs.

    “Similarly, expectancy may or may not actually be matched across conditions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning

    The framework proposed here may help guide the selection of a control group, but it cannot definitively identify the ideal one for any particular study.

    “The framework we propose here may help guide the selection of a control group, but it cannot definitively identify the ideal one for any particular study.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Although focal and control interventions may both in theory be equally intensive, participants may not engage with them both equally.

    “Although focal and control interventions may both in theory be equally intensive, participants may not engage with them both equally.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Highest classes of comparison strength (Class II and I) require therapeutic control conditions that may be matched in intensity and non-specific factors including expectancy.

    “The highest classes of comparison strength (Class II and I) require therapeutic control conditions that may be matched in intensity and non-specific factors including expectancy.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    Dismantling Design and Additive Design controls provide very strong comparisons (Class I), but only for the components being subtracted or added and not for the intervention as a whole.

    “Dismantling Design and Additive Design controls provide very strong comparisons (Class I), but only for the components being subtracted or added and not for the intervention as a whole.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation

    As a general rule, clinical trials should only be run when there is the expectation that the treatment being studied may be beneficial (i.e., equipoise).

    “As a general rule, clinical trials should only be run when there is the expectation that the treatment being studied may be beneficial (i.e., equipoise)54.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [54] Freedman, B. Equipoise and the ethics of clinical research. N. Engl. J. Med. 317, 427–431 (1987). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The contribution of study-related human support in mHealth RCTs makes categorization challenging.

    “The contribution of study-related human support in mHealth RCTs also makes categorization challenging.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationreasoning

    Scientific questions related to comparisons with other mHealth interventions are best addressed using mHealth Minimal Active controls or mHealth Comparative Efficacy controls.

    “Scientific questions related to comparisons with other mHealth interventions are best addressed using mHealth Minimal Active controls or mHealth Comparative Efficacy controls.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The therapeutic vs. non-therapeutic two-category scheme requires collapsing across a theoretically wide range of non-therapeutic and therapeutic controls.

    “However, it requires collapsing across a theoretically wide range of non-therapeutic (i.e., No Treatment, Placebo-Minimal, Placebo-Active) and therapeutic controls.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Clinical trialists may reasonably disagree about how a particular control condition should be categorized.

    “Moreover, clinical trialists may reasonably disagree about how a particular control condition should be categorized.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    The boundary between TAU-Minimal and TAU-Active may often be fuzzy in contexts where TAU is heterogeneous.

    “The boundary between TAU-Minimal and TAU-Active may often be fuzzy in contexts where TAU is heterogeneous (i.e., patients receive differing amounts and/or type of treatment).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationcitation

    At later stages of research, stronger comparisons are warranted.

    “At later stages of research, stronger comparisons are warranted13.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [13] Gold, S. M. et al. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry 4, 725–732 (2017). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisenone given

    The 11-category scheme is designed to characterize important differences between control conditions in mHealth RCTs.

    “The 11-category scheme is designed to characterize important differences between control conditions in mHealth RCTs.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning

    In contexts where trust is limited between community members and academic research teams, providing an active control may be necessary for building trust and completing recruitment and enrollment goals for an RCT.

    “In contexts where trust is limited between community members and academic research teams, providing an active control may be necessary for building trust and completing recruitment and enrollment goals for an RCT.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Four-category scheme distinguishes between therapeutic and non-therapeutic controls, defined as non-specific and specific active controls, while combining minimal treatment controls into a single group.

    “This scheme also distinguishes between therapeutic and non-therapeutic controls, defined as non-specific and specific active controls42,43, while combining minimal treatment controls into a single group.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [42] Goldberg, S. B. et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin. Psychol. Rev. https://doi.org/10.1016/j.cpr.2017.10.011 (2017). source

      Not checked in the free run.

    • cites [43] Galante, J. et al. Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: a systematic review and meta-analysis of randomised controlled trials. PLoS Med. 18, 1–40 (2021). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Dismantling Designs may have removed all theoretically therapeutic ingredients and therefore be better categorized as Placebo-Active.

    “Dismantling Designs, although categorized as intended to be therapeutic in our scheme, may have removed all theoretically therapeutic ingredients34 and therefore be better categorized as Placebo-Active.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [34] Bell, E. C., Marcus, D. K. & Goodlad, J. K. Are the parts as good as the whole? A meta-analysis of component treatment studies. J. Consult. Clin. Psychol. 81, 722–736 (2013). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The passive vs. active two-category scheme ignores whether a control condition is intended to be therapeutic.

    “A downside of this scheme is it ignores whether a control is intended to be therapeutic.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationcitation

    In early stages of research, No Treatment controls may be very appropriate to evaluate intervention effects beyond passage of time and related confounds.

    “In early stages of research39,40, No Treatment controls may be very appropriate in order to evaluate intervention effects beyond the passage of time and related confounds (e.g., regression to the mean)41.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [39] Onken, L. S., Carroll, K. M., Shoham, V., Cuthbert, B. N. & Riddle, M. Reenvisioning clinical science: unifying the discipline to improve the public health. Clin. Psychol. Sci. 2, 22–34 (2014). source

      Not checked in the free run.

    • cites [40] Rounsaville, B. J., Carroll, K. M. & Onken, L. S. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin. Psychol. Sci. Pract. 8, 133–142 (2001). source

      Not checked in the free run.

    • cites [41] Bland, J. M. & Altman, D. G. Statistic notes: regression towards the mean. BMJ 308, 1499 (1994). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationcitation

    Clinical trialists are faced with balancing controlling threats to internal validity with statistical power.

    “clinical trialists are faced with balancing controlling threats to internal validity (where stronger comparisons provide more confidence that observed differences between intervention and control groups are due to the intervention itself) with statistical power (where stronger comparisons are expected to produce smaller between-group differences that require larger sample sizes for detection).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [11] Mohr, D. C. et al. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother. Psychosom. 78, 275–284 (2009). source

      Not checked in the free run.

    • cites [13] Gold, S. M. et al. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry 4, 725–732 (2017). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Four control conditions can be used to evaluate the effects of mHealth in the context of non-mHealth interventions.

    “Four control conditions can be used to evaluate the effects of mHealth in the context of non-mHealth interventions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    There may be advantages to having simpler schemes (e.g., for meta-analysis).

    “there may be advantages to having simpler schemes (e.g., for meta-analysis).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    TAU-Active is challenging to include in four-category scheme.

    “One control condition that is challenging to include in this scheme is TAU-Active.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationcitation

    As consensus is reached regarding the categorization of control conditions in mHealth RCTs, this information can be used by regulators, researchers, industry stakeholders, and patients and clinicians.

    “As consensus is reached regarding the categorization of control conditions in mHealth RCTs, this information can be used by bodies charged with regulating these technologies (e.g., FDA)60, researchers seeking to adequately power mHealth RCTs, industry stakeholders involved in investing and marketing, and ultimately patients and clinicians deciding when to use a given mHealth tool.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [60] Sim, I. Mobile devices and health. N. Engl. J. Med. 381, 956–968 (2019). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The passive vs. active two-category scheme for control conditions is used within the meta-analytic literature.

    “it is used within the meta-analytic literature44”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [44] Firth, J. et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 16, 287–298 (2017). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Selecting a control condition has ethical implications around access to care, scientific rigor, and bias.

    “Selecting a control condition has ethical implications around access to care, scientific rigor, and bias.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    In theory, between-group effect sizes should become smaller as the comparison strength increases from Class V to Class I.

    “In theory, between-group effect sizes should become smaller as the comparison strength increases from Class V to Class I.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given

    One issue not addressed by the proposed scheme is the ethical dimension of study design.

    “One issue not addressed by our scheme, but of paramount importance, is the ethical dimension of study design.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Studies commonly involve interaction between participants and study staff, although it can be hard to evaluate the extent and nature of this interaction from published RCTs.

    “Studies commonly involve interaction between participants and study staff, although it can be hard to evaluate the extent and nature of this interaction from published RCTs49.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [49] Meyer, A., Wisniewski, H. & Torous, J. Coaching to support mental health apps: exploratory narrative review. JMIR Hum. Factors 9, e28301 (2022). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation

    As a program of research matures, increasingly rigorous and theoretically therapeutic control conditions may be warranted, both for ethical and scientific reasons.

    “As a program of research matures (e.g., moves through the stages of intervention development)11,39,40, increasingly rigorous and theoretically therapeutic control conditions may be warranted, both for ethical (e.g., beneficence and non-maleficence)53 and scientific reasons (i.e., determining how a novel treatment compares with established treatments).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [11] Mohr, D. C. et al. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother. Psychosom. 78, 275–284 (2009). source

      Not checked in the free run.

    • cites [39] Onken, L. S., Carroll, K. M., Shoham, V., Cuthbert, B. N. & Riddle, M. Reenvisioning clinical science: unifying the discipline to improve the public health. Clin. Psychol. Sci. 2, 22–34 (2014). source

      Not checked in the free run.

    • cites [40] Rounsaville, B. J., Carroll, K. M. & Onken, L. S. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin. Psychol. Sci. Pract. 8, 133–142 (2001). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation

    Particularly in under-resourced settings and when working with vulnerable populations, No Treatment control conditions may be inappropriate as they may involve withholding interventions with known therapeutic value.

    “Particularly in under-resourced settings and when working with vulnerable populations, No Treatment control conditions may be inappropriate as they may involve withholding interventions with known therapeutic value50,51.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [50] Boruch, R. F., Victor, T. & Cecil, J. S. Resolving ethical and legal problems in randomized experiments. Crime & Delinquency 46, 330–353 (2016). source

      Not checked in the free run.

    • cites [51] Pavone, I. R. Legal responses to placebo-controlled trials in developing countries. Global Bioethics 27, 76–90 (2016). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    Five-category scheme collapses across levels of placebo controls, TAU controls, mHealth controls, and non-mHealth controls.

    “A five-category scheme collapses across levels of placebo controls, TAU controls, mHealth controls, and non-mHealth controls.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    Adaptive designs and factorial designs in mHealth RCTs are challenging to categorize.

    “Adaptive designs in which the treatment that is delivered changes over time (e.g., sequential multiple assignment randomized controlled trial [SMART])48 and factorial designs that evaluate multiple aspects of an mHealth intervention at once are challenging to categorize.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [48] Collins, L. M., Murphy, S. A. & Strecher, V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART). New methods for more potent eHealth interventions. Am. J. Prev. Med. 32, S112–S118 (2007). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.

    Interpretationreasoning

    New meta-analyses sensitive to the impact of control groups may provide more accurate effect size estimates and results of prior meta-analyses may need to be reexamined in light of these considerations.

    “New meta-analyses sensitive to the impact of controls groups may provide more accurate effect size estimates and results of prior meta-analyses may need to be reexamined in light of these considerations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    Placebo-Minimal controls for some non-specific factors while Placebo-Active can theoretically control for all non-specific factors, particularly when time and expectancy are matched.

    “Placebo-Minimal controls for some non-specific factors (e.g., minimal amounts of time, attention, or expectancy) while a Placebo-Active can theoretically control for all non-specific factors, particularly when time and expectancy are matched.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Non-EBT non-mHealth controls provide strong comparisons (Class II), but weaker comparisons than frontline, non-mHealth EBTs.

    “Non-EBT non-mHealth controls provide strong comparisons (Class II), but weaker comparisons than frontline, non-mHealth EBTs.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    Five-category scheme ignores variations in intensity and evidence base which may influence scientific inferences and effect sizes.

    “Although this scheme can help describe the types of comparisons, it ignores variations in intensity and evidence base which may influence scientific inferences and effect sizes.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    No Treatment controls provide the lowest tier (Class V).

    “No Treatment controls provide the lowest tier (Class V).”
    Quote in the paperSubstantial claim
55 of 55
  • The paper relies on this without support.

    The 11 control condition types are comprehensive and capable of differentiating between the wide variety of control conditions in mHealth literature.

    “We intend this typology to be comprehensive and capable of differentiating between the wide variety of control conditions appearing in the mHealth literature.”
  • The paper relies on this without support.

    The five-tier comparison strength gradation validly orders control conditions by strength.

    “Table 2 displays a five-tier scheme for grading the comparison strength provided by the 11 control conditions.”
  • The paper relies on this without support.

    The five dimensions chosen are the relevant dimensions for differentiating control conditions in mHealth RCTs.

    “Our proposed typology considers five dimensions (Table 1): intended to be therapeutic, intensity, intensity match, masking/expectancy match, and received by both groups.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Additive Design is marked as not received by both groups despite its example

    Minor

    Table 1 marks the Additive Design control as not received by both groups, but its example gives both groups the Weight Watchers digital program; the focal group receives an additional app.

  • Placebo-Minimal is said to be received by both groups, but Table 1 says otherwise

    Minor

    The comparison-strength discussion says both Class IV control conditions are received by both groups. Table 1 lists Placebo-Minimal as received by both groups only "No/maybe," not yes.

  • TAU-Active is called active in the prose but unclear in Table 3

    Minor

    The prose says every condition other than No Treatment and TAU-Minimal is active, which includes TAU-Active. Table 3 instead assigns TAU-Active "Unclear" in the active-versus-non-active scheme.

3 of 3

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Wampold, B. E., Frost, N. D. & Yulish, N. E. Placebo effects in psychotherapy: a flawed concept and a contorted history. Psychol. Conscious. Theory Res. Pract. 3, 108–120 (2016).
  2. Goldberg, S. B. et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin. Psychol. Rev. 59, 52–60 (2018). · DOI · Paper page

Cited by

Sorted by citations

Authors
Goldberg, S. B., Sun, S., Carlbring, P., & Torous, J.
Affiliations
  • University of Wisconsin–Madison (US)
  • Brown University (US)
  • Stockholm University (SE)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Goldberg, Simon B.
Venue
npj Digital Medicine
Published
2023-09-30
Volume
6
Issue
1
Pages
181-181
ISSN
2398-6352 (ISSN-L)
OpenAlex
W4387210055
Cited by
75
References
61
Citations by year
2026: 22 · 2025: 30 · 2024: 19 · 2023: 4
FWCI
3.79
Type
journal article
Language
en
Open access
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • PsyArXiv (OSF Preprints) (submittedVersion, cc-by)
  • PsyArXiv (OSF Preprints) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (K23AT010879, K23AT011173)
  • Hope for Depression Research Foundation (Defeating Depression Award)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
mobile health, control conditions, randomized controlled trials, mental health interventions, behavioral health, meta-analysis comparability, decision tree, research ethics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review